DexCare scored $50 million in a Series B funding round led by Transformation Capital. Existing investors Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures and SpringRock Ventures also participated.
The Series B comes less than a year after a $20 million fundraise from March.
The Providence Health spinout offers a platform for health systems to...
